Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (600721.SS)
CNY 7.06
(0.28%)
CNY 7.06
(0.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 369.27 Million | 349.88 Million | 281.35 Million | 84.53 Million | 262.01 Million | 419.18 Million |
| Cost of Revenue | 227.83 Million | 210.21 Million | 168.7 Million | 221.43 Million | 134.97 Million | 230.96 Million |
| Gross Profit | 141.43 Million | 139.66 Million | 112.65 Million | -136.9 Million | 127.04 Million | 188.22 Million |
| Operating Expenses | 163.12 Million | 109.19 Million | 29.59 Million | 72.27 Million | 70.52 Million | 59.01 Million |
| Selling, General and Administrative Expenses | 52.23 Million | 33.05 Million | 25.24 Million | 22.96 Million | 24.98 Million | 20.53 Million |
| Research and Development Expenses | 31.86 Million | 27.48 Million | 5.25 Million | 6.11 Million | - | - |
| Other Expenses | 79.02 Million | 48.65 Million | -903.11 Thousand | 43.19 Million | 45.54 Million | 2.34 Million |
| Cost and Expenses | 351.32 Million | 319.41 Million | 198.29 Million | 293.7 Million | 205.49 Million | 289.97 Million |
| Operating Income | 17.95 Million | 29.49 Million | 63.54 Million | -370.79 Million | 81.55 Million | -794.04 Million |
| Interest Expense | 63.37 Thousand | 112.57 Thousand | 47.21 Thousand | 751.58 Thousand | 869.42 Thousand | 991.88 Thousand |
| Income Tax Expense | 3.5 Million | 2.61 Million | 2.3 Million | 4.08 Million | 8.3 Million | 21.28 Million |
| Earnings before Tax | 16.79 Million | -32.11 Million | 62.17 Million | -315.67 Million | 42.06 Million | -791.69 Million |
| Net Income | 12.97 Million | -34.72 Million | 59.82 Million | -319.76 Million | 34.38 Million | -807.86 Million |
| Earnings Per Share Basic | 0.03 | -0.09 | 0.16 | -0.82 | 0.09 | -2.02 |
| Earnings Per Share Diluted | 0.03 | -0.09 | 0.16 | -0.82 | 0.09 | -2.02 |
| Weighted Average Shares Outstanding | 379.3 Million | 375.72 Million | 375.13 Million | 389.86 Million | 399.82 Million | 400.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 379.3 Million | 375.72 Million | 375.13 Million | 389.86 Million | 399.82 Million | 400.38 Million |
| Gross Margin | 0.38 | 0.40 | 0.40 | -1.62 | 0.48 | 0.45 |
| EBIT Margin | 0.11 | 0.16 | 0.38 | -1.57 | 0.43 | 0.39 |
| Profit Margin | 0.04 | -0.10 | 0.21 | -3.78 | 0.13 | -1.93 |
| EBITDA | 39.62 Million | -2.22 Million | 91.78 Million | -267.57 Million | 73.23 Million | -629.03 Million |
| Earnings Before Tax Margin | 0.05 | 0.08 | 0.23 | -4.39 | 0.31 | -1.89 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 94.32 Million | 104.02 Million | 90.87 Million | 103.56 Million | 369.27 Million | 98.49 Million |
| Cost of Revenue | 53.02 Million | 60.67 Million | 43.38 Million | 50.59 Million | 188.19 Million | 48.59 Million |
| Gross Profit | 41.3 Million | 43.35 Million | 47.48 Million | 52.97 Million | 181.08 Million | 49.9 Million |
| Operating Expenses | 25.82 Million | 42.6 Million | 25.13 Million | 29.43 Million | 111.7 Million | 29.14 Million |
| Selling, General and Administrative Expenses | 28.75 Million | 21.76 Million | 18.11 Million | -30.41 Million | - | 42.69 Million |
| Research and Development Expenses | 8.32 Million | 7.94 Million | 6 Million | 10.66 Million | - | 8.6 Million |
| Other Expenses | -11.24 Million | -12.9 Million | 38.97 Thousand | -1.04 Million | -1.47 Million | -52.13 Thousand |
| Cost and Expenses | 78.85 Million | 103.27 Million | 68.52 Million | 80.02 Million | 299.89 Million | 77.74 Million |
| Operating Income | 2.26 Million | 746.2 Thousand | 21.98 Million | -2.81 Million | 17.95 Million | 5.71 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 961.26 Thousand | 781.78 Thousand | 1.35 Million | 854.32 Thousand | 3.5 Million | 974.28 Thousand |
| Earnings before Tax | 2.25 Million | 2.16 Million | 22.01 Million | -3.86 Million | 16.48 Million | 5.66 Million |
| Net Income | 1.29 Million | 1.99 Million | 20.66 Million | -4.71 Million | 12.97 Million | 4.69 Million |
| Earnings Per Share Basic | 0.00 | 0.01 | 0.05 | -0.01 | - | 0.01 |
| Earnings Per Share Diluted | 0.00 | 0.01 | 0.05 | -0.01 | - | 0.01 |
| Weighted Average Shares Outstanding | 383.12 Million | 378.17 Million | 381.94 Million | 383.16 Million | 379.3 Million | 378.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 383.12 Million | 384.13 Million | 382.65 Million | 383.14 Million | 379.3 Million | 378.4 Million |
| Gross Margin | 0.44 | 0.42 | 0.52 | 0.51 | 0.49 | 0.51 |
| EBIT Margin | -0.12 | 0.05 | 0.26 | -0.03 | - | 0.49 |
| Profit Margin | 0.01 | 0.02 | 0.23 | -0.05 | 0.04 | 0.05 |
| EBITDA | -11.72 Million | 5.67 Million | 23.3 Million | -3.13 Million | - | 47.78 Million |
| Earnings Before Tax Margin | 0.02 | 0.01 | 0.24 | -0.03 | 0.05 | 0.06 |
002958
600098
1815
PRYMF
EPLAS
BRN